X-act Cologne Clinical Research GmbH   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cologne Germany (1994)

Organization Overview

First Clinical Trial
2013
NCT01621256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

X-act Cologne Clinical Research GmbH | X-act Cologne Research GmbH

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Deafness (Phase 2)

Ear Diseases (Phase 2)

Hearing Disorders (Phase 2)

Hearing Loss (Phase 2)

Hearing Loss, Sensorineural (Phase 2)

Lichen Planus (Phase 2)

Lichen Planus, Oral (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 16
  • # of Trial APIs: 30